The high prevalence of indeterminate QFT-Plus assay in a large cohort of patients hospitalized because of SARS-CoV-2 infection, is directly linked to the impaired IFN-γ production in the mitogen-nil condition and the reduction in peripheral blood T-lymphocytes in COVID-19 patients. Here, IFNG is linked to COVID-19.